Feedback / Questions
antolimab (AK002) - Allakos
antolimab subcutaneous (AK002 SC) - Allakos
http://clinicaltrials.gov/ct2/show/NCT04324268
Aug 14, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next